日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells

转录因子E2F1对ARF和TAp73肿瘤抑制基因的独特调控作用,使得区分癌细胞和正常生长细胞成为可能。

Zhou, Yaxuan; Nakajima, Rinka; Shirasawa, Mashiro; Fikriyanti, Mariana; Watanabe, Ako; Yang, Caiwei; Iwanaga, Ritsuko; Bradford, Andrew P; Kurayoshi, Kenta; Araki, Keigo; Ohtani, Kiyoshi

Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells

肿瘤抑制因子E2F靶基因启动子元件在癌细胞中特异性驱动基因表达的应用

Kurayoshi, Kenta; Tanaka, Masakazu; Nakajima, Rinka; Zhou, Yaxuan; Shirasawa, Mashiro; Fikriyanti, Mariana; Fujisawa, Jun-Ichi; Iwanaga, Ritsuko; Bradford, Andrew P; Araki, Keigo; Ohtani, Kiyoshi

Transcriptional Activation Mechanisms and Target Genes of the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1

人类T细胞白血病病毒1型癌基因产物Tax的转录激活机制和靶基因

Shirasawa, Mashiro; Nakajima, Rinka; Zhou, Yaxuan; Fikriyanti, Mariana; Iwanaga, Ritsuko; Bradford, Andrew P; Kurayoshi, Kenta; Araki, Keigo; Ohtani, Kiyoshi

The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB.

转录共激活因子 DEAD/H 盒 5 (DDX5) 基因是转录因子 E2F1 的靶标,而 E2F1 又受到肿瘤抑制因子 pRB 的调控

Nakajima Rinka, Zhou Yaxuan, Shirasawa Mashiro, Fikriyanti Mariana, Iwanaga Ritsuko, Bradford Andrew P, Kurayoshi Kenta, Araki Keigo, Ohtani Kiyoshi

Activation of the CDK7 Gene, Coding for the Catalytic Subunit of the Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) and General Transcription Factor II H, by the Trans-Activator Protein Tax of Human T-Cell Leukemia Virus Type-1.

人类 T 细胞白血病病毒 1 型的反式激活蛋白 Tax 激活 CDK7 基因,该基因编码细胞周期蛋白依赖性激酶 (CDK) 激活激酶 (CAK) 的催化亚基和通用转录因子 II H

Shirasawa Mashiro, Nakajima Rinka, Zhou Yaxuan, Zhao Lin, Fikriyanti Mariana, Iwanaga Ritsuko, Bradford Andrew P, Kurayoshi Kenta, Araki Keigo, Ohtani Kiyoshi

Engineered Polymeric Nanovector for Intracellular Peptide Delivery in Antitumor Therapy

用于抗肿瘤治疗中细胞内肽递送的工程化聚合物纳米载体

Zhang, Xi; Zhang, Mingming; Huang, Sijun; Ohtani, Kiyoshi; Xu, Li; Guo, Yi

Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression

E2F-RB-p53通路在肿瘤抑制中的作用日益增强

Zhou, Yaxuan; Nakajima, Rinka; Shirasawa, Mashiro; Fikriyanti, Mariana; Zhao, Lin; Iwanaga, Ritsuko; Bradford, Andrew P; Kurayoshi, Kenta; Araki, Keigo; Ohtani, Kiyoshi

Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool

E2F活性失调作为一种癌细胞特异性治疗工具

Nakajima, Rinka; Zhao, Lin; Zhou, Yaxuan; Shirasawa, Mashiro; Uchida, Ayato; Murakawa, Hikaru; Fikriyanti, Mariana; Iwanaga, Ritsuko; Bradford, Andrew P; Araki, Keigo; Warita, Tomoko; Ohtani, Kiyoshi

Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes

E2F依赖性肿瘤抑制基因和生长相关基因激活对二聚体伴侣DP的需求存在差异

Komori, Hideyuki; Goto, Yasuko; Kurayoshi, Kenta; Ozono, Eiko; Iwanaga, Ritsuko; Bradford, Andrew P; Araki, Keigo; Ohtani, Kiyoshi

Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells

人类T细胞白血病病毒I型Tax在人类T细胞中人类端粒酶逆转录酶(hTERT)基因表达中的作用

Hara, Toshifumi; Matsumura-Arioka, Yuuki; Ohtani, Kiyoshi; Nakamura, Masataka